Advertisement

Examination of Non-Infected Operatively-Excised Bioprostheses in the Aortic Valve Position to Determine the Reason for their Dysfunction

  • William C. Roberts
    Correspondence
    Corresponding author: William C. Roberts, MD, Baylor Scott & White Heart and Vascular Institute, 621 N. Hall Street, Suite H-030, Dallas, Texas 75226. Tel.: (214) 820-7911(O); fax: (214) 820-7533.
    Affiliations
    Baylor Scott & White Heart and Vascular Institute, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas

    Department of Internal Medicine, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas

    Department of Pathology, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas
    Search for articles by this author
  • Yusuf M. Salam
    Affiliations
    Baylor Scott & White Heart and Vascular Institute, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas
    Search for articles by this author
  • Charles S. Roberts
    Affiliations
    Baylor Scott & White Heart and Vascular Institute, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas

    Department of Cardiac Surgery, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas
    Search for articles by this author
      Described herein are findings in 55 non-infected bioprostheses that had been in the aortic valve position from 2 to 276 months (mean 107). The major purpose of this study was to illustrate the variable causes prompting excision of the bioprostheses. Fifty-three (96%) patients survived ≥ 30 days following the bioprosthetic excision and 50 (91%) patients lived ≥1 year postoperatively. The techniques used to explant the bioprostheses appear to vary considerably among the operating surgeons.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kostyunin AE
        • Yuzhalin AE
        • Rezvova MA
        • Ovcharenko EA
        • Glushkova TV
        • Kutikhin AG.
        Degeneration of bioprosthetic heart valves: update 2020.
        J Am Heart Assoc. 2020; 20 (9)e018506
      1. Roberts WC, Manzoori S, Hassan MH, Salam YM, Roberts CS. Infective endocarditis involving a bioprosthesis in the aortic valve position with operative excision. Am J Cardiol (In Press).

        • Salaun E
        • Clavel MA
        • Rodés-Cabau J
        • Pibarot P.
        Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
        Heart. 2018; 104: 1323-1332
        • Dvir D
        • Bourguignon T
        • Otto CM
        • Hahn RT
        • Rosenhek R
        • Webb JG
        • Treede H
        • Sarano ME
        • Feldman T
        • Wijeysundera HC
        • Topilsky Y
        • Aupart M
        • Reardon MJ
        • Mackensen GB
        • Szeto WY
        • Kornowski R
        • Gammie JS
        • Yoganathan AP
        • Arbel Y
        • Borger MA
        • Simonato M
        • Reisman M
        • Makkar RR
        • Abizaid A
        • McCabe JM
        • Dahle G
        • Aldea GS
        • Leipsic J
        • Pibarot P
        • Moat NE
        • Mack MJ
        • Kappetein AP
        • Leon MB.
        Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves.
        Circulation. 2018; 137: 388-399
        • Patlolla SH
        • Schaff HV
        • Stulak JM
        • Michelena HI
        • Saran N
        • King KS
        • Dearani JA.
        Bicuspid aortic valve repair: causes of valve failure and long-term outcomes.
        Ann Thorac Surg. 2021; 111: 1225-1232
        • Kuroda Y
        • Marui A
        • Arai Y
        • Nagasawa A
        • Tsumaru S
        • Arakaki R
        • Iida J
        • Wada Y
        • Tamai Y
        • Fukushima T
        • Soga Y.
        Impact of dialysis in patients undergoing bioprosthetic aortic valve replacement.
        Interact Cardiovasc Thorac Surg. 2021; 33: 348-353
        • Hirota M
        • Isomura T
        • Yoshida M
        • Katsumata C
        • Ito F
        • Watanabe M.
        Subvalvular pannus overgrowth after mosaic bioprosthesis implantation in the aortic position.
        Ann Thorac Cardiovasc Surg. 2016; 22: 108-111
        • Vola M
        • Fuzellier JF
        • Campisi S
        • Roche F
        • Favre JP
        • Isaaz K
        • Morel J
        • Gerbay A.
        Closed chest human aortic valve removal and replacement: technical feasibility and one year follow-up.
        Int J Cardiol. 2016; 211: 71-78
        • Hamamoto M
        • Kobayashi T
        • Ozawa M
        • Yoshimura K.
        Pure cusp tear of trifecta bioprosthesis 2 years after aortic valve replacement.
        Ann Thorac Cardiovasc Surg. 2017; 23: 157-160
        • Liu C
        • Doig F
        • Naidoo R
        • Tesar P.
        Redo aortic valve replacement following bio-bentall's procedure.
        Heart Lung Circ. 2019; 28: e131-e133
        • Beliaev AM
        • Haydock DA.
        How to replace a bioprosthetic aortic valve within the bentall graft.
        J Card Surg. 2020; 35: 656-658
        • Kataoka H
        • Tanaka H
        • Toshida T
        • Ebato M
        • Suzuki H.
        Intraoperative trifecta valve malfunction.
        Ann Thorac Surg. 2021; 112: e107-e109
        • Cibin G
        • D'Onofrio A
        • Fabozzo A
        • Tarzia V
        • Gerosa G
        Valve-shaped thrombus underneath an aortic bioprosthesis.
        J Card Surg. 2021; 36: 3846-3847
        • Della Barbera M
        • Valente M
        • Basso C
        • Pettenazzo E
        • Thiene G
        The pathology of early failure in Mitroflow pericardial valve bioprosthesis (12A/LX).
        Cardiovasc Pathol. 2021; 55107373
        • Watanabe T
        • Tokunaga N
        • Maruno K
        • Yoshida H
        • Kuinose M.
        Redo aortic valve replacement due to early structural valve deterioration in a trifecta valve: a case report.
        Int J Surg Case Rep. 2021; 86106381
        • Dohi M
        • Doi K
        • Yaku H.
        Early stenosis of an aortic porcine bioprosthesis due to thrombosis: case report and literature review.
        J Thorac Cardiovasc Surg. 2015; 149: e83-e86